Effects of Chest Physiotherapy in Hyperventilation Syndrome
SHV
2 other identifiers
observational
46
1 country
1
Brief Summary
Hyperventilation syndrome induce dyspnea and altered quality of life. the aim of this study is to assess the impact of chest physiotherapy on hyperventilation syndrome' symptoms
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2021
CompletedFirst Submitted
Initial submission to the registry
May 27, 2022
CompletedFirst Posted
Study publicly available on registry
August 4, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2023
CompletedAugust 31, 2023
August 1, 2023
1.8 years
May 27, 2022
August 30, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
change of Nijmegen score
Nijmegen score is measured at baseline and after 5 weeks. The Nijmegen questionnaire allows to assess hyperventilation symptoms. the minimum and maximum values are between 0 to 64, and higher scores mean a worse outcome.
5 weeks
Secondary Outcomes (4)
change of Nijmegen Score
1 week
change of Hospital Anxiety and Depression score (HAD)
5 weeks
change of Short Form-36 score (SF-36)
5 weeks
change of Dyspnea-12 score
5 weeks
Interventions
chest physiotherapy session including: * nasal ventilation * decrease of respiratory rate without increasement of Tidal volume * abdomino-diaphragmatic ventilation
Eligibility Criteria
patients with hyperventilation syndrome adressed for chest physiotherapy
You may qualify if:
- patients addressed for hyperventilation syndrome
- patient aged 18 years or over
- patient able to consent and having sign a consent form
You may not qualify if:
- respiratory disease (COPD, interstitial lung disease, bronchiectasis, cystic fibrosis, uncontrolled asthma)
- patient with an inability to complete questionaires
- refusal of participation
- patient under tutorship or curatorship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
BEAUMONT
Morlaix, 29600, France
Related Publications (2)
Chenivesse C, Similowski T, Bautin N, Fournier C, Robin S, Wallaert B, Perez T. Severely impaired health-related quality of life in chronic hyperventilation patients: exploratory data. Respir Med. 2014 Mar;108(3):517-23. doi: 10.1016/j.rmed.2013.10.024. Epub 2013 Nov 7.
PMID: 24269004BACKGROUNDKiesel K, Burklow M, Garner MB, Hayden J, Hermann AJ, Kingshott E, McCullough G, Ricard R, Stubblefield G, Volz J, Waskiewicz D, Englert A. EXERCISE INTERVENTION FOR INDIVIDUALS WITH DYSFUNCTIONAL BREATHING: A MATCHED CONTROLLED TRIAL. Int J Sports Phys Ther. 2020 Feb;15(1):114-125.
PMID: 32089963BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 27, 2022
First Posted
August 4, 2022
Study Start
October 1, 2021
Primary Completion
August 1, 2023
Study Completion
August 1, 2023
Last Updated
August 31, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share